Effect of immunosuppressants on the expansion and function of naturally occurring regulatory T cells

Transplant Immunology

Volumn 18, Issue 2, 2007, Pages 94-100

  Lim, Dong Gyun ^a   Joe, In Yi ^a   Park, Youn Hee ^a   Chang, Sung Ho ^a   Wee, Yu Mee ^a   Han, Duck Jong ^a   Kim, Song Cheol ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Immunoregulation; Immunosuppressants; Naturally occurring Treg cells; Proliferation

Indexed keywords

ABATACEPT; ALLOANTIGEN; CD40 LIGAND MONOCLONAL ANTIBODY; CYCLOSPORIN A; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE FUNCTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION TOLERANCE;

EID: 36048954800     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2007.05.005     Document Type: Article

References (42)

1. Dantal J., and Soulillou J.P. Immunosuppressive drugs and the risk of cancer after organ transplantation. N Engl J Med 352 13 (2005) 1371-1373
2. Auchincloss H. In search of the elusive Holy Grail: the mechanisms and prospects for achieving clinical transplantation tolerance. Am J Transplant 1 1 (2001) 6-12
3. Lechler R.I., Garden O.A., and Turka L.A. The complementary roles of deletion and regulation in transplantation tolerance. Nat Rev Immunol 3 (2003) 147-158
4. Taylor P.A., Noelle R.J., and Blazar B.R. CD4+CD25+ immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med 193 11 (2001) 1311-1317
5. Hara M., Kingsley C.I., Niimi M., Read S., Turvey S.E., Bushell A.R., et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 166 6 (2001) 3789-3796
6. Graca L., Thompson S., Lin C.Y., Adams E., Cobbold S.P., and Waldmann H. Both CD4+CD25+ and CD4+CD25- regulatory cells mediate dominant transplantation tolerance. J Immunol 168 11 (2002) 5558-5565
7. Salama A.D., Najafian N., Clarkson M.R., Harmon W.E., and Sayegh M.H. Regulatory CD25+ T cells in human kidney transplant recipients. J Am Soc Nephrol 14 6 (2003) 1643-1651
8. Meloni F., Vitulo P., Bianco A.M., Paschetto E., Morosini M., Cascina A., et al. Regulatory CD4+CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome. Transplantation 77 5 (2004) 762-766
9. Bluestone J.A., and Abbas A.K. Natural versus adaptive regulatory T cells. Nat Rev Immunol 3 (2003) 253-257
10. Shevach E.M. CD4+CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2 (2002) 389-400
11. Jonuleit H., and Schmitt E. The regulatory T cell family: distinct subsets and their interrelations. J Immunol 171 12 (2003) 6323-6327
12. Hoffmann P., Ermann J., Edinger M., Fathman C.G., and Strober S. Donor-type CD4+CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med 196 3 (2002) 389-399
13. Sanchez-Fueyo A., Weber M., Domenig C., Strom T.B., and Zheng X.X. Tracking the immunoregulatory mechanisms active during allograft tolerance. J Immunol 168 5 (2002) 2274-2281
14. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 188 2 (1998) 287-296
15. Klein L., Khazaie K., and von Boehmer H. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc Natl Acad Sci U S A 100 15 (2003) 8886-8891
16. + T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J Immunol 166 5 (2001) 3008-3018
17. + regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 194 5 (2001) 629-644
18. + T cells through TGF-TGF-receptor interactions in type 1 diabetes. Proc Natl Acad Sci U S A 100 19 (2003) 10878-10883
19. Lim S.M., Kogure K., and White D.J. Steroid treatment depresses the production of transplantation tolerance. Transplant Proc 22 4 (1990) 1989-1990
20. Wang C., Sun J., Sheil A.G., McCaughan G.W., and Bishop G.A. A short course of methylprednisolone immunosuppression inhibits both rejection and spontaneous acceptance of rat liver allografts. Transplantation 72 1 (2001) 44-51
21. Larsen C.P., Elwood E.T., Alexander D.Z., Ritchie S.C., Hendrix R., Tucker-Burden C., et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381 6581 (1996) 434-438
22. Almeida A.R., Legrand N., Papiernik M., and Freitas A.A. Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers. J Immunol 169 9 (2002) 4850-4860
23. D'Cruz L.M., and Klein L. Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling. Nat Immunol 6 11 (2005) 1152-1159
24. Zeiser R., Nguyen V.H., Beilhack A., Buess M., Schulz S., Baker J., et al. Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production. Blood 108 1 (2006) 390-399
25. Porter S.B., Liu B., Rogosheske J., Levine B.L., June C.H., Kohl V.K., et al. Suppressor function of umbilical cord blood-derived CD4+CD25+ T-regulatory cells exposed to graft-versus-host disease drugs. Transplantation 82 1 (2006) 23-29
26. Franchimont D. Overview of the actions of glucocorticoids on the immune response: a good model to characterize pathways of immunosuppression for new treatment strategies. Ann N Y Acad Sci 1024 (2004) 124-137
27. Battaglia M., Stabilini A., and Roncarolo M.G. Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 105 12 (2005) 4743-4748
28. Battaglia M., Stabilini A., Migliavacca B., Horejs-Hoeck J., Kaupper T., and Roncarolo M.G. Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J Immunol 177 12 (2006) 8338-8347
29. Valmori D., Tosello V., Souleimanian N.E., Godefroy E., Scotto L., Wang Y., et al. Rapamycin-mediated enrichment of T cells with regulatory activity in stimulated CD4+ T cell cultures is not due to the selective expansion of naturally occurring regulatory T cells but to the induction of regulatory functions in conventional CD4+ T cells. J Immunol 177 2 (2006) 944-949
30. Strauss L., Whiteside T.L., Knights A., Bergmann C., Knuth A., and Zippelius A. Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin. J Immunol 178 1 (2007) 320-329
31. Coenen J.J., Koenen H.J., van Rijssen E., Hilbrands L.B., and Joosten I. Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells. Blood 107 3 (2006) 1018-1023
32. Lin H., Bolling S.F., Linsley P.S., Wei R.Q., Gordon D., Thompson C.B., et al. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J Exp Med 178 5 (1993) 1801-1806
33. Larsen C.P., Alexander D.Z., Hollenbaugh D., Elwood E.T., Ritchie C., Aruffo A., et al. CD40-gp39 interactions play a critical role during allograft rejection: suppression of allograft rejection by blockade of the CD40-gp39 pathway. Transplantation 61 1 (1996) 4-9
34. Hancock W.W., Sayegh M.H., Zheng X.G., Peach R., Linsley P.S., and Turka L.A. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. Proc Natl Acad Sci U S A 93 24 (1996) 13967-13972
35. + T cells and prolonged graft survival in a CTLA4-dependent manner. J Immunol 164 1 (2000) 512-521
36. Li Y., Li X.C., Zheng X.X., Wells A.D., Turka L.A., and Strom T.B. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat Med 5 11 (1999) 1298-1302
37. Oderup C., Malm H., Ekberg H., Qi Z., Veress B., Ivars F., et al. Costimulation blockade-induced cardiac allograft tolerance: inhibition of T cell expansion and accumulation of intragraft CD4+Foxp3+ T cells. Transplantation 82 11 (2006) 1493-1500
38. Allison A.C., and Eugui E.M. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF). Clin Transplant 10 1 Pt 2 (1996) 77-84
39. Shibutani S., Inoue F., Aramaki O., Akiyama Y., Matsumoto K., Shimazu M., et al. Effects of immunosuppressants on induction of regulatory cells after intratracheal delivery of alloantigen. Transplantation 79 8 (2005) 904-913
40. Blaha P., Bigenzahn S., Koporc Z., Schmid M., Langer F., Selzer E., et al. The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade. Blood 101 7 (2003) 2886-2893
41. Kawai M., Kitade H., Mathieu C., Waer M., and Pirenne J. Inhibitory and stimulatory effects of cyclosporine A on the development of regulatory T cells in vivo. Transplantation 79 9 (2005) 1073-1077
42. Tian L., Lu L., Yuan Z., Lamb J.R., and Tam P.K. Acceleration of apoptosis in CD4+CD8+ thymocytes by rapamycin accompanied by increased CD4+CD25+ T cells in the periphery. Transplantation 77 2 (2004) 183-189